Lauren Oliva is the U.S. Lead for Regulatory Policy at Biogen, where she develops and implements policy strategies to support innovation in drug development. Her work focuses on aligning science, regulation, and advocacy to better serve patients and ensure their needs are reflected in how new therapies are developed. She’s driven by a belief that good policy should be clear, collaborative, and focused on delivering value to the people it’s meant to serve. With 15 years of experience in the pharmaceutical industry, Lauren is committed to building cross-sector partnerships that advance thoughtful, patient-centered solutions. She has contributed to multi-stakeholder efforts through the Critical Path Institute, the Clinical Trials Transformation Initiative (CTTI), the National Academies’ Drug Forum, and the Drug Information Association (DIA). Lauren earned her Doctor of Pharmacy from Rutgers University and has served as adjunct faculty at MCPHS University in Boston. In her free time, she enjoys hiking, beach days, live music, and time with loved ones.